Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 24, 2001

View Archived Issues

Low Share Prices, Cash Positions Expected To Trigger M&A Activity

Some EU Member States Resist Lifting Moratorium On GMOs

French Government Agrees On Measures To Support Biotech

Tissue Engineering Draws Much Interest At German Trade Fair

Axxima Raises EUR30.6M In Third Financing Round

IntegraGen Secures Access To Obesity, Diabetes Gene Data

Berna Biotech, Bachem Enter Joint Venture For Peptide Vaccines

Other News To Note

Transgene Takes Gene Therapy Product Into Phase II Studies

ReGen Raising Funds To Move Colostrinin Trials Forward

De Novo, Roche Collaborate On Chemical Design Platform

MediGene Gets Positive Results In First Genital Warts Phase III

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...